SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.750
+0.010 (0.27%)
At close: Jan 2, 2026, 4:00 PM EST
3.770
+0.020 (0.53%)
After-hours: Jan 2, 2026, 4:10 PM EST
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $178.53 million as of January 2, 2026. Its market cap has increased by 374.10% in one year.
Market Cap
178.53M
Enterprise Value
73.83M
1-Year Change
374.10%
Ranking
Category
Stock Price
$3.75
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has increased from $130.75M to $178.53M, an increase of 36.53%. That is a compound annual growth rate of 6.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 178.05M | 408.46% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
| Feb 9, 2021 | 130.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.97B |
| Johnson & Johnson | 499.11B |
| AbbVie | 406.25B |
| UnitedHealth Group | 300.34B |
| AstraZeneca | 288.12B |
| Novartis AG | 266.00B |
| Merck & Co. | 262.18B |
| Novo Nordisk | 227.63B |